CVS Health
CVS
2,074 hedge funds and large institutions have $118B invested in CVS Health in 2026 Q2 according to their latest regulatory filings, with 323 funds opening new positions, 781 increasing their positions, 736 reducing their positions, and 108 closing their positions.
199% more first-time investments, than exits
New positions opened: 323 | Existing positions closed: 108
58% more funds holding in top 10
Funds holding in top 10: 19 → 30 (+11)
48% more capital invested
Capital invested by funds: $79.4B → $118B (+$38.1B)
32% more call options, than puts
Call options by funds: $2.05B | Put options by funds: $1.55B
10% more funds holding
Funds holding: 1,880 → 2,074 (+194)
2.29% more ownership
Funds ownership: 86.89% → 89.18% (+2.3%)
6% more repeat investments, than reductions
Existing positions increased: 781 | Existing positions reduced: 736
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.24B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1B |
| 3 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$707M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$385M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$334M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$662M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$424M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$406M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$395M |
| 5 |
GCM
Glenview Capital Management
New York
|
-$301M |
CVS Hedge Fund Activity: Q2 2026 in Review
2,074 of the 8,346 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q2 2026, worth a combined $118B — up 48% from $79.4B a quarter earlier.
Buyers outnumbered sellers: 323 funds opened new CVS positions and 108 closed out — a net gain of 215 holders — while 781 added to existing stakes and 736 trimmed.
The largest buyer was Bank of America, adding an estimated $1.24B. The largest seller was JP Morgan Chase, cutting an estimated $662M.
- 2,074 institutional investors held CVS Health (CVS) as of Q2 2026, up from 1,880 in Q1 2026.
- Funds reported $118B of CVS Health stock for Q2 2026, up 48% quarter-over-quarter.
- 323 funds opened new CVS Health positions in Q2 2026 and 108 closed out, a net change of +215 holders.
- The largest CVS Health buyer in Q2 2026 was Bank of America, an estimated $1.24B added.
- The largest CVS Health seller in Q2 2026 was JP Morgan Chase, an estimated $662M sold.
Based on aggregated 13F filings for Q2 2026.